Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.
Also called NCT06674460
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 600 participants
- Registry
-
NCT06674460
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06674460. Randomized; quadruple masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2027-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Treatment of Acute Ischemic Stroke With Edaravone Dexborneol Sublingual Tablets in Small Vessel Disease
- Acronym
- TASTE-SVD
- Condition
- Cerebral Small Vessel Disease
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Edaravone Dexborneol Sublingual Tablets
- Intervention (Drug)
- Placebo
- Lead sponsor
- Peking Union Medical College Hospital
Record details
- Record id
cardio:ct-nct06674460- Content hash
081b854ddb700f503e0afe6a56343e07fa622eb2c19beb8cf0501990106dcfd1